AVR anteris technologies global corp.

6.09%

$6.27

Interview with Wayne and Alan Kohler, page-23

First 23 Last

Share
Profile

Follow
Investek

325 Posts.

94

21/04/22

12:09

Post #: 60950366
Share

Originally posted by synaphai: ↑

They were actually delisted a month later but that's because their primary business is in China and the new presidential administration decided to enact new guidelines on companies that operate in China. Hopefully that will be cleared up soon but that's immaterial to Anteris and the original uplisting went smoothly.

I've been in other US based companies that have uplisted to Nasdaq and I've never felt like the price fluctuations changed that much. A lot still depends on volume and company catalysts and coverage in the financial media. Lower volumes tend to make stock more volatile and there are Nasdaq listed stocks that have relatively low volumes as well.

Anteris could be a little different though because the stock has had no presence here in the US. Many brokerages still don't offer the OTC version, AMEUF, for trading. So an uplisting could have more of an upward impact, at least at some point . Especially if our potential starts getting talked about in media outlets. I'd consider writing an article for Seeking Alpha, a popular stock idea site. Maybe I could get some help here in preparing it but that's down the road after uplisting, whenever that actually happens. Things usually take longer than expected.

Expand

Thanks for the detailed reply.

I suppose I'm just not as optimistic that a NASDAQ up listing is the panacea many think it will be.

Take a look at Avita, $AVR since moving to a primary IS listing. I appreciate that is only one example however from memory only about 50% of Aussie companies who make the jump see higher stock prices.

Last edited by Investek: 21/04/22

AVR Price at posting: $19.00 Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

First 23 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.27		Change 0.360(6.09%)		Mkt cap ! $97.17M

Open	High	Low	Value	Volume
$5.93	$6.30	$5.91	$107.9K	17.39K

Buyers (Bids)

No.	Vol.	Price($)
1	3500	$6.12

Sellers (Offers)

Price($)	Vol.	No.
$6.27	200	1

View Market Depth

No.	Vol.	Price($)
1	3500	6.120
1	2000	6.100
1	1000	6.000
1	1250	5.950
1	857	5.830

Price($)	Vol.	No.
6.270	200	1
6.300	463	1
6.400	130	1
6.500	255	1
6.550	1092	1

Last trade - 15.42pm 27/06/2025 (20 minute delay)

AVR (ASX) Chart

Interview with Wayne and Alan Kohler, page-23

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Interview with Wayne and Alan Kohler, page-23

Top Stories

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News